ArticleClinical rheumatology2024

Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort.

Anna Gamba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.